Want to see CJMB full AI Analyst Report?
CJMB Stock Chart & Stats
$2.11
-$0.07(-2.78%)
At close: 4:00 PM EDT
$2.11
-$0.07(-2.78%)
Day’s Range― - ―
52-Week Range$0.65 - $5.61
Previous CloseN/A
Volume1.77M
Average Volume (3M)93.00K
Market Cap
$12.94M
Enterprise Value$5.82M
Total Cash (Recent Filing)$860.27K
Total Debt (Recent Filing)$2.14M
Price to Earnings (P/E)―
Beta-0.41
Next Earnings
Nov 13, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.00
Shares Outstanding5,752,368
10 Day Avg. Volume61,605
30 Day Avg. Volume92,995
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)2.09
Price to Sales (P/S)0.85
P/FCF Ratio-0.94
Enterprise Value/Market Cap0.45
Enterprise Value/Revenue1.14
Enterprise Value/Gross Profit2.86
Enterprise Value/Ebitda-0.61
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Healthy Gross MarginsRelatively stable gross margins show that the company continues to retain meaningful value from each dollar of sales. If revenue stabilizes, this margin base could support operating improvement, although current costs remain too high to convert gross profit into earnings.
Upstream Asset ExpansionThe announced upstream acquisitions could materially expand Callan JMB’s operating asset base and establish a larger energy platform. Successful closing and integration would provide a clearer strategic direction and create potential for more substantial future revenue generation.
Expanded Financing CapacityA larger equity facility gives the company additional potential access to capital for acquisitions, drilling-related spending, and general liquidity needs. This expands strategic flexibility over the next several months, although the financing structure can also create dilution.
Bears Say
Severe Revenue ContractionThe sharp, multi-year revenue decline indicates a materially smaller operating base and weak commercial momentum. Lower sales reduce the company’s ability to absorb fixed costs, fund investment internally, and recover profitability without a sustained improvement in demand or new asset contribution.
Deep Losses And Cost PressureHealthy gross margins are being overwhelmed by operating expenses, showing that the current cost structure lacks sufficient operating leverage. Persistent deep losses can consume capital, constrain investment choices, and make a return to sustainable profitability dependent on substantial cost or revenue improvement.
Weak Balance Sheet And Cash BurnDeeply negative operating and free cash flow limit self-funding capacity while the sharply reduced equity cushion makes leverage more burdensome. This combination increases reliance on external financing and leaves less resilience to execution setbacks, additional losses, or delays in planned transactions.
Callan JMB, Inc. News
CJMB FAQ
What was Callan JMB, Inc.’s price range in the past 12 months?
Callan JMB, Inc. lowest stock price was $0.65 and its highest was $5.61 in the past 12 months.
What is Callan JMB, Inc.’s market cap?
Callan JMB, Inc.’s market cap is $12.94M.
When is Callan JMB, Inc.’s upcoming earnings report date?
Callan JMB, Inc.’s upcoming earnings report date is Nov 13, 2026 which is in 31 days.
How were Callan JMB, Inc.’s earnings last quarter?
Callan JMB, Inc. released its earnings results on Aug 13, 2026. The company reported -$0.218 earnings per share for the quarter.
Is Callan JMB, Inc. overvalued?
According to Wall Street analysts Callan JMB, Inc.’s price is currently Overvalued.
Does Callan JMB, Inc. pay dividends?
Callan JMB, Inc. does not currently pay dividends.
What is Callan JMB, Inc.’s EPS estimate?
Callan JMB, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Callan JMB, Inc. have?
Callan JMB, Inc. has 5,752,368 shares outstanding.
What happened to Callan JMB, Inc.’s price movement after its last earnings report?
Callan JMB, Inc. reported an EPS of -$0.218 in its last earnings report. Following the earnings report the stock price went up 5.023%.
Which hedge fund is a major shareholder of Callan JMB, Inc.?
Currently, no hedge funds are holding shares in CJMB
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Callan JMB, Inc.
Callan JMB Inc., operating primarily through its subsidiary Coldchain Technology Services, LLC, specializes in providing temperature-controlled logistics solutions specifically for the life sciences sector. The company's services include comprehensive frozen shipping capabilities essential for a wide range of sensitive biological and medical materials. These critical shipments encompass items such as personalized medicines, cell-based therapies, stem cells, cell lines, vaccines, diagnostic samples, reproductive materials (including semen, eggs, and embryos), cord blood, organs, biopharmaceutical products, infectious substances, and other vital commodities. Additionally, Callan JMB Inc. offers packaging services for other perishable (non-pharmaceutical) client goods, alongside technical support. The company was founded in 2006 and is based in Spring Branch, Texas.
Technical Analysis
Freightos Limited
―
Jayud Global Logistics Limited Class A
―
Armlogi Holding Corp
―
New Century Logistics (BVI) Ltd.
―
Smart Logistics Global Limited
―
Ownership Overview
55.47% Insiders
0.41% Mutual Funds
4.68% Other Institutional Investors
39.32% Public Companies and
Individual Investors